Showing results (891-900 of 2,915) with videos related to

Sort By:
Pageof 292
Cancer Gene Therapy|April 30, 2005
Infectivity enhanced, hTERT promoter-based conditionally replicative adenoviruses are useful for SCLC treatmentJunji Uchino, Koichi Takayama, Akiko Harada, et al.
Cancer Gene Therapy|May 14, 2005
Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme: biological and clinical resultsFederico Colombo, Luisa Barzon, Elisa Franchin, et al.
Cancer Gene Therapy|May 14, 2005
Immunity to squamous carcinoma in mice immunized with dendritic cells transfected with genomic DNA from squamous carcinoma cellsInSug O-Sullivan, Lauren K Ng, Don M Martinez, et al.
Cancer Gene Therapy|April 9, 2005
The potential of oncolytic virus therapy for pancreatic cancerHideki Kasuya, Shin Takeda, Shuji Nomoto, et al.
Cancer Gene Therapy|November 27, 2004
Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent miceOliver Ebert, Sonal Harbaran, Katsunori Shinozaki, et al.
Cancer Gene Therapy|November 27, 2004
Use and specificity of breast cancer antigen/milk protein BA46 for generating anti-self-cytotoxic T lymphocytes by recombinant adeno-associated virus-based gene loading of dendritic cellsYong Liu, Maurizio Chiriva-Internati, Changxuan You, et al.
Cancer Gene Therapy|November 27, 2004
Intratumoral administration of immature dendritic cells following the adenovirus vector encoding CD40 ligand elicits significant regression of established myelomaYongqing Liu, Dajing Xia, Fang Li, et al.
Cancer Gene Therapy|June 16, 2005
Coexpression of CD40L and CD70 by semiallogenic tumor cells induces anti-tumor immunityCarine Cormary, Elsa Hiver, Bernard Mariamé, et al.
Cancer Gene Therapy|May 7, 2005
Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytesFrank Grünebach, Katrin Kayser, Markus M Weck, et al.
Cancer Gene Therapy|September 3, 2005
Liposome-DNA complexes infused intravenously inhibit tumor angiogenesis and elicit antitumor activity in dogs with soft tissue sarcomaD Kamstock, A Guth, R Elmslie, et al.
Pageof 292